Los Angeles, CA20 Active Studies

Parkinsons Disease Clinical Trials in Los Angeles, CA

Find 20 actively recruiting parkinsons disease clinical trials in Los Angeles, CA. Connect with local research sites and explore new treatment options.

20
Active Trials
18
Sponsors
38,539
Enrolling

Recruiting Parkinsons Disease Studies in Los Angeles

About Parkinsons Disease Clinical Trials in Los Angeles

Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.

There are currently 20 parkinsons disease clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 38,539 participants. Research is being sponsored by Parkinson's Foundation, Michael J. Fox Foundation for Parkinson's Research, Boston Scientific Corporation and 15 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Parkinsons Disease Clinical Trials in Los Angeles — FAQ

Are there parkinsons disease clinical trials in Los Angeles?

Yes, there are 20 parkinsons disease clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Los Angeles?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.

Are clinical trials in Los Angeles free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.

What parkinsons disease treatments are being tested?

The 20 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.

Data updated September 2, 2026 from ClinicalTrials.gov